Advertisement

ACIP Releases 2014 Adult Immunization Schedule — Physician’s First Watch

Medical News |
February 4, 2014

ACIP Releases 2014 Adult Immunization Schedule

By Kelly Young

The CDC's Advisory Committee on Immunization Practices (ACIP) has released its 2014 immunization schedule for adults.

Among the changes for this year:

  • Haemophilus influenzae type B (Hib) vaccine should no longer be considered for unvaccinated adults with HIV because of their low risk for Hib infection.

  • The inactivated influenza vaccine can be used in patients with hives-only allergy to eggs, but only with additional safety precautions. The recombinant influenza vaccine, which does not contain egg protein, can be safely used in patients with egg allergy of any severity.

  • Patients aged 11 years and older who have not received tetanus, diphtheria, and acellular pertussis (Tdap) vaccine should receive a dose of Tdap, followed by a tetanus and diphtheria toxoids (Td) booster every 10 years thereafter.

Reader Comments (2)

nora figueroa Resident, Other

I would like to recivie all information

Antoine COQUEREL, MD, PhD Physician, Pharmacology/Pharmacy, University hospital (Caen, 14033, France)

Very interest, especially for comprisons with various countries including France & EC

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement